ArticleDiabetes, obesity & metabolism2024

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease.

Jinnie J Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.